PCRonline 🫀

🔎Valve selection remains one of the most important decisions in TAVI. In this article from The Essentials #TAVI, Won-Keun Kim reviews how valve design can influence procedural success, hemodynamic performance, coronary access, and future redo interventions. 🔗Read the article: pcronline.com/Cases-resource… #StructuralHeart #InterventionalCardiology #CardioEd #CardioEducation #CardioTwitter

PCR JAPAC TAVI Fellowship and Development Programme – here we go! This new educational framework, dedicated to the training, mentorship and career development of future structural heart intervention implanters across the Asia-Pacific region, got together for kick-off meetings on 9 July in Beijing 🇨🇳 and 13 July in Tokyo 🇯🇵, bringing together mentors and fellows committed to advancing skills, sharing experience and building lasting professional networks. Under the programme direction of Sam Dawkins, this initiative reflects our long-standing commitment to education that extends beyond individual Courses by supporting physicians throughout their professional journey. We look forward to following the participants as they embark on this exciting programme! 🔵Mentors for China: Xiangbin Pan, Zhi-Cheng Jing & Yun Ching Fu 🔵Mentors for Japan: Kentaro Hayashida, @OhnoTuri, Norio Tada, Masaki Izumo, Shinichi Shirai & Mamoru Nanasato Find out more about this Fellowship programme: pcronline.com/Courses/PCR-JA… #TAVI #TAVR #cardioed #internationalcollaboration

🌡️ Heatwaves are more than a public health challenge. They are a test of hospital #resilience. ⚠️Increased hospital pressure can disrupt cardiovascular care pathways and delay essential treatment. ❓Is your institution prepared? Check with #RESILCard 👉 tinyurl.com/4xfcztbb

PCR Perspectives: Vulnerable plaque - what’s next? 📺 & 🎧pcronline.com/Cases-resource… What defines a vulnerable plaque today? @hect2701 and @sbrugaletta review the imaging tools used to identify high-risk lesions and discuss the ongoing debate around the best treatment strategy, from systemic management to emerging focal therapies. Also available as a podcast! #interventionalcardiology #EuroPCR

Congratulations to @Drroxmehran on receiving the 2026 Andreas Grüntzig Ethica Award from @PCRonline for her impactful work on improving outcomes for patients undergoing interventional procedures. #CardioX #Cardiology

🫀 El marcapasos permanente es la complicación más frecuente tras el TAVI. ¿Pueden los glucocorticoides prevenirlo? El ensayo GLUCO-TAVI muestra una reducción relativa del 50%. Vía @EuroInterventio 👇 eurointervention.pcronline.com/article/glucoc… #Hemodinamica #TAVI

ViTAL® is vital! Thank you to everyone who attended this week's AICT-AsiaPCR #AictPCR transformative learning session in Singapore, with facilitators Michael Haude, Mohd Ali Rosli and Huay Cheem Tan. We hope to see you on 23 and 24 October 2026 in 🇸🇬 for top-notch education in #interventionalcardiology at the Official Course of the Asian Pacific Society of Interventional Cardiology @APSIC6 - view the programme here lnkd.in/eM_c9QN5 #CardioEd

Journal Club: Quantitative flow ratio versus fractional flow reserve: 2-year follow-up of the FAVOR III Europe trial 🔗pcronline.com/PCR-Publicatio… @ANazmiCalik & @M_Gokalp_DrMG review this study which reports the prespecified 2-year follow-up results of the FAVOR III Europe trial, comparing QFR-guided versus FFR-guided coronary revascularisation in patients with angiographically intermediate coronary stenoses. Published in @EuroInterventio #interventionalcardiology #science #clinicalresearch

Strengthening international collaboration through education. During our dedicated joint session at Beijing Valves 🇨🇳, Mao Chen, PCR-CIT China Chengdu Valves Course Director, shared PCR's commitment to building even stronger partnerships with the Chinese interventional cardiology community, stressing the need to create more opportunities for physicians to learn from one another, exchange experience, and contribute to a truly global educational community. Thank you to Guangyuan Song and the Beijing Valves team for your invitaton & warm welcome, and to everyone who joined us: we look forward to continuing this collaboration in the years ahead! #interventionalcardiology #internationalcollaboration

My Toolkit 🧰⚙️🪛: Protection wire through superficial femoral artery micropuncture in patients undergoing TAVI: when, how, why 🔗pcronline.com/Cases-resource… Hostile iliofemoral anatomy can turn transfemoral TAVI access into a challenge. This My Toolkit, submitted by @andreka_judit and @gabor_gtpresents, proposes a simple ipsilateral safety wire technique using superficial femoral artery micropuncture to preserve rapid bailout access while minimising vascular trauma. Reviewed by @ANazmiCalik #interventionalcardiology #TAVR #CardioED

Estenosis aórtica y enfermedad coronaria: ¿qué tratamos primero? Una pregunta sin respuesta única que el intervencionista se hace en cada caso. La evidencia y las consideraciones prácticas. #Hemodinamica #TAVI

Generations of researchers, innovators, and clinical scientists in the field of interventional cardiology have benefited from the extraordinary generosity and vision of @JHDHFoundation and Jon DeHaan. As William Wijns, PCR Honorary Chairman, shared: “Jon DeHaan was always encouraging us to ‘push the needle’ in order to advance patient benefit. The Foundation’s impact and legacy are massive for the innovation community, the medical community and, above all, patients and their families.” On behalf of PCR, we extend our deepest condolences to his family, friends, and colleagues.

Your next presentation could be on the #PCRLV stage. As Karl Poon's experience shows, sharing your work at #PCRLV can open the door to valuable discussions and recognition from the global Heart Team. Submit your best Scientific Abstract, Clinical Case, Innovation or Late-breaking Trial by 1 September. 🔗 pcronline.com/Courses/PCR-Lo… @drmaisano @drtpatterson @nicolo_piazza @didier_tchetche

New EuroIntervention graphical abstract on antithrombotic strategy after PCI • High bleeding/low ischaemic → DAPT abbreviation + SAPT (ticagrelor) • Mixed risk → DAPT de-escalation • High ischaemic/low bleeding → Standard DAPT (1yr) or even prolonged dual antithrombotic

1/ New RCT: AnchorMan vs. Watchman for left atrial appendage closure. SAFE-PROTECT (EuroIntervention 2026, DOI 10.4244/EIJ-D-25-01168, n=216) — 12-month results, published yesterday. 🧵

Don’t miss the opportunity to update your knowledge in this dynamic and constantly evolving field. #PCRRiovalves . Mark in your 📅 and visit PCR platform for the programme.

#TAVI is done, but the day after a holosystolic murmur is noted. a VSD is discovered and subsequently treated by the authors of this case. something great to know for #TAVI operators @EIJCaseReports @PCRonline @crfheart @tctmd @secardiologia @shci_sec

🫀Aortic stenosis and coronary artery disease: which should be treated first? In this article, @HenrykDreger reviews the evidence and practical considerations that guide treatment sequencing in patients undergoing #TAVI. Read more: pcronline.com/Cases-resource… #PCI #StructuralHeart #InterventionalCardiology #CardioEd #CardioEducation